Metadichol ® A Novel Nano Lipid; GPR 120 Agonist
نویسندگان
چکیده
منابع مشابه
G protein - coupled receptor 120 ( GPR 120 )
1The authors thank Trine Poulsen, Annette K. Nielsen, and Kasper B. Poulsen for their skilled technical assistance. The project was fi nancially supported by the Danish Council for Strategic Research (FØSU 2101-07-0111). 2Corresponding author: [email protected] ABSTRACT: Free fatty acids (FFA) are produced in the intestine by microbial fermentation. Recently, a family of G protein-coupled re...
متن کاملMetadichol, A Novel ROR Gamma Inverse Agonist and Its Applications in Psoriasis
Psoriasis affects 3% of the population worldwide, and there is no known cure. Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, and Crohn’s disease. Psoriasis treatments today include steroid and vitamin D3 cream, ultraviolet light, and immune systemsuppressing medications such as methotrexate. The T cells responsible for psoriasis are Th1...
متن کاملMetadichol ®. A Novel Inverse Agonist of Aryl Hydrocarbon Receptor (AHR) and NRF2 Inhibitor
Metadichol ® a novel nano emulsion of lipid alcohols is an Inverse agonist of Vitamin D Receptor (VDR). In this communication, we show that Metadichol is an inverse agonist of the nuclear receptor AHR (Aryl Hydrocarbon receptor) and also an inhibitor of NRF2 (Nuclear factor (erythroid-derived 2)-like 2) and is a transcription factor that is ubiquitously expressed at low levels in all human orga...
متن کاملMetadichol ®. A Novel Inverse Agonist of Aryl Hydrocarbon Receptor (AHR) and NRF2 Inhibitor
Metadichol ® a novel nano emulsion of lipid alcohols is an Inverse agonist of Vitamin D Receptor (VDR). In this communication, we show that Metadichol is an inverse agonist of the nuclear receptor AHR (Aryl Hydrocarbon receptor) and also an inhibitor of NRF2 (Nuclear factor (erythroid-derived 2)-like 2) and is a transcription factor that is ubiquitously expressed at low levels in all human orga...
متن کاملSolid Lipid Nanoparticles and Nano Lipid Carriers: as Novel Solid Lipid Based Drug Carrier
Interest in lipid based drug delivery has developed over the past decade fuelled by a better understanding of the multiple roles lipids may play in enhancing oral bioavailability. Moreover, the emergence of novel excipients with acceptable regulatory and safety profiles coupled with advances in formulation technologies have greatly improved the potential for successful lipid based formulations....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes & its Complications
سال: 2017
ISSN: 2639-9326
DOI: 10.33425/2639-9326.1005